Table 3.

Diagnostic performance of PBMCs miR-27a-3p and serum CA 9-9 in the validating dataset of pancreatic cancer and BPD group

VariablePancreatic cancer vs. BPD
SensitivitySpecificityAUC (95% CI)
miR-27a-3p82.2%76.7%0.840 (0.787–0.885)
CA 19-972.9%75.7%0.788 (0.730–0.839)
combinationa85.3%81.6%0.886 (0.837–0.923)
  • aCombination of PBMC miR-27a-3p and serum CA19-9.

  • blogit(P = pancreatic cancer) = −2.4597 + 0.0239 × miR-27a-3p + 0.0064 × CA19-9.